🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to determine if the endocannabinoid (...
Status
Completed
Location
Novant Health Forsyth Medical Center
Start Date
2019-01-25
Trial ID
NCT03752021
Treatments Being Tested
The PREPPeD study proposes that predelivery placenta-derived maternal circu...
Status
Unknown
Location
Oslo University Hospital
Start Date
2016-09-15
Trial ID
NCT03100084
Treatments Being Tested
Preterm birth complicates 10% of all pregnancies and is the leading cause o...
Status
Active Not Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ostetricia e Patologia Ostetrica
Start Date
2025-03-11
Trial ID
NCT06891508
Treatments Being Tested
Congenital heart defects (CHD), as the leading cause of birth defects, affe...
Status
Recruiting
Location
Nantes University Hospital
Start Date
2025-02-28
Trial ID
NCT06690151
This study evaluates the utility of expanded panel non-invasive prenatal te...
Status
Completed
Location
University of California, San Francisco
Start Date
2020-02-12
Trial ID
NCT04311749
Jeffrey Chang MD is conducting a research study to learn more about the inc...
Status
Completed
Location
UCSD Medical Center
Start Date
2009-09
Trial ID
NCT00989781
This study aim to describe dynamics of immunologic markers C1 inhibitor, C3...
Status
Completed
Location
University Hospital Brno
Start Date
2018-09-08
Trial ID
NCT03664999
Treatments Being Tested
The primary purpose is to assess whether there is transfer of Certolizumab ...
Status
Completed
Location
11
Start Date
2014-01
Trial ID
NCT02019602
SARS-CoV-2, the agent responsible for pandemic COVID-19 infection, is trans...
Status
Terminated
Location
Chu Saint-Etienne
Start Date
2021-12-01
Trial ID
NCT05124574
Few studies have focused on malaria co-infections, mainly caused by Plasmod...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-15
Trial ID
NCT06769815